nodes	percent_of_prediction	percent_of_DWPC	metapath
Polythiazide—Hyperuricaemia—Thiotepa—sarcoma	0.0235	0.0235	CcSEcCtD
Polythiazide—Blood uric acid increased—Thiotepa—sarcoma	0.0222	0.0222	CcSEcCtD
Polythiazide—Hyperuricaemia—Vincristine—sarcoma	0.0208	0.0208	CcSEcCtD
Polythiazide—Aplastic anaemia—Dactinomycin—sarcoma	0.0203	0.0203	CcSEcCtD
Polythiazide—Hyperuricaemia—Mitoxantrone—sarcoma	0.0203	0.0203	CcSEcCtD
Polythiazide—Blood uric acid increased—Vincristine—sarcoma	0.0197	0.0197	CcSEcCtD
Polythiazide—Blood uric acid increased—Mitoxantrone—sarcoma	0.0191	0.0191	CcSEcCtD
Polythiazide—Hyperuricaemia—Etoposide—sarcoma	0.0169	0.0169	CcSEcCtD
Polythiazide—Blood uric acid increased—Etoposide—sarcoma	0.0159	0.0159	CcSEcCtD
Polythiazide—Hyperglycaemia—Thiotepa—sarcoma	0.0123	0.0123	CcSEcCtD
Polythiazide—Jaundice—Thiotepa—sarcoma	0.0119	0.0119	CcSEcCtD
Polythiazide—Agranulocytosis—Thiotepa—sarcoma	0.0114	0.0114	CcSEcCtD
Polythiazide—Agranulocytosis—Dactinomycin—sarcoma	0.0113	0.0113	CcSEcCtD
Polythiazide—Photosensitivity reaction—Vincristine—sarcoma	0.0111	0.0111	CcSEcCtD
Polythiazide—Glycosuria—Epirubicin—sarcoma	0.0108	0.0108	CcSEcCtD
Polythiazide—Hyperglycaemia—Mitoxantrone—sarcoma	0.0106	0.0106	CcSEcCtD
Polythiazide—Jaundice—Mitoxantrone—sarcoma	0.0102	0.0102	CcSEcCtD
Polythiazide—Cramp muscle—Etoposide—sarcoma	0.0102	0.0102	CcSEcCtD
Polythiazide—Glycosuria—Doxorubicin—sarcoma	0.01	0.01	CcSEcCtD
Polythiazide—Jaundice cholestatic—Epirubicin—sarcoma	0.00997	0.00997	CcSEcCtD
Polythiazide—Agranulocytosis—Mitoxantrone—sarcoma	0.00981	0.00981	CcSEcCtD
Polythiazide—Hyperuricaemia—Epirubicin—sarcoma	0.00945	0.00945	CcSEcCtD
Polythiazide—Jaundice cholestatic—Doxorubicin—sarcoma	0.00923	0.00923	CcSEcCtD
Polythiazide—Blood uric acid increased—Epirubicin—sarcoma	0.00892	0.00892	CcSEcCtD
Polythiazide—Agitation—Thiotepa—sarcoma	0.00874	0.00874	CcSEcCtD
Polythiazide—Hyperuricaemia—Doxorubicin—sarcoma	0.00874	0.00874	CcSEcCtD
Polythiazide—Jaundice—Etoposide—sarcoma	0.00852	0.00852	CcSEcCtD
Polythiazide—Leukopenia—Thiotepa—sarcoma	0.00852	0.00852	CcSEcCtD
Polythiazide—Leukopenia—Dactinomycin—sarcoma	0.00845	0.00845	CcSEcCtD
Polythiazide—Blood uric acid increased—Doxorubicin—sarcoma	0.00826	0.00826	CcSEcCtD
Polythiazide—Aplastic anaemia—Epirubicin—sarcoma	0.00823	0.00823	CcSEcCtD
Polythiazide—Agranulocytosis—Etoposide—sarcoma	0.00816	0.00816	CcSEcCtD
Polythiazide—Agitation—Vincristine—sarcoma	0.00775	0.00775	CcSEcCtD
Polythiazide—Aplastic anaemia—Doxorubicin—sarcoma	0.00761	0.00761	CcSEcCtD
Polythiazide—Thrombocytopenia—Thiotepa—sarcoma	0.0076	0.0076	CcSEcCtD
Polythiazide—Vertigo—Vincristine—sarcoma	0.00758	0.00758	CcSEcCtD
Polythiazide—Leukopenia—Vincristine—sarcoma	0.00755	0.00755	CcSEcCtD
Polythiazide—Thrombocytopenia—Dactinomycin—sarcoma	0.00755	0.00755	CcSEcCtD
Polythiazide—Anorexia—Thiotepa—sarcoma	0.0074	0.0074	CcSEcCtD
Polythiazide—Leukopenia—Mitoxantrone—sarcoma	0.00735	0.00735	CcSEcCtD
Polythiazide—Anorexia—Dactinomycin—sarcoma	0.00735	0.00735	CcSEcCtD
Polythiazide—Photosensitivity—Epirubicin—sarcoma	0.00724	0.00724	CcSEcCtD
Polythiazide—Vascular purpura—Epirubicin—sarcoma	0.00711	0.00711	CcSEcCtD
Polythiazide—Paraesthesia—Thiotepa—sarcoma	0.00697	0.00697	CcSEcCtD
Polythiazide—Decreased appetite—Thiotepa—sarcoma	0.00675	0.00675	CcSEcCtD
Polythiazide—Thrombocytopenia—Vincristine—sarcoma	0.00674	0.00674	CcSEcCtD
Polythiazide—Photosensitivity—Doxorubicin—sarcoma	0.0067	0.0067	CcSEcCtD
Polythiazide—Decreased appetite—Dactinomycin—sarcoma	0.0067	0.0067	CcSEcCtD
Polythiazide—Constipation—Thiotepa—sarcoma	0.00664	0.00664	CcSEcCtD
Polythiazide—Purpura—Epirubicin—sarcoma	0.0066	0.0066	CcSEcCtD
Polythiazide—Vascular purpura—Doxorubicin—sarcoma	0.00658	0.00658	CcSEcCtD
Polythiazide—Muscle spasms—Etoposide—sarcoma	0.00657	0.00657	CcSEcCtD
Polythiazide—Thrombocytopenia—Mitoxantrone—sarcoma	0.00657	0.00657	CcSEcCtD
Polythiazide—Anorexia—Vincristine—sarcoma	0.00656	0.00656	CcSEcCtD
Polythiazide—Anorexia—Mitoxantrone—sarcoma	0.00639	0.00639	CcSEcCtD
Polythiazide—Paraesthesia—Vincristine—sarcoma	0.00618	0.00618	CcSEcCtD
Polythiazide—Urticaria—Thiotepa—sarcoma	0.00617	0.00617	CcSEcCtD
Polythiazide—Vertigo—Etoposide—sarcoma	0.00614	0.00614	CcSEcCtD
Polythiazide—Leukopenia—Etoposide—sarcoma	0.00612	0.00612	CcSEcCtD
Polythiazide—Purpura—Doxorubicin—sarcoma	0.00611	0.00611	CcSEcCtD
Polythiazide—Paraesthesia—Mitoxantrone—sarcoma	0.00602	0.00602	CcSEcCtD
Polythiazide—Decreased appetite—Vincristine—sarcoma	0.00599	0.00599	CcSEcCtD
Polythiazide—Constipation—Vincristine—sarcoma	0.00589	0.00589	CcSEcCtD
Polythiazide—Decreased appetite—Mitoxantrone—sarcoma	0.00583	0.00583	CcSEcCtD
Polythiazide—Orthostatic hypotension—Epirubicin—sarcoma	0.00581	0.00581	CcSEcCtD
Polythiazide—Constipation—Mitoxantrone—sarcoma	0.00573	0.00573	CcSEcCtD
Polythiazide—Hypersensitivity—Thiotepa—sarcoma	0.00572	0.00572	CcSEcCtD
Polythiazide—Hypersensitivity—Dactinomycin—sarcoma	0.00568	0.00568	CcSEcCtD
Polythiazide—Asthenia—Thiotepa—sarcoma	0.00557	0.00557	CcSEcCtD
Polythiazide—Asthenia—Dactinomycin—sarcoma	0.00553	0.00553	CcSEcCtD
Polythiazide—Thrombocytopenia—Etoposide—sarcoma	0.00546	0.00546	CcSEcCtD
Polythiazide—Pancreatitis—Epirubicin—sarcoma	0.00539	0.00539	CcSEcCtD
Polythiazide—Orthostatic hypotension—Doxorubicin—sarcoma	0.00538	0.00538	CcSEcCtD
Polythiazide—Urticaria—Mitoxantrone—sarcoma	0.00533	0.00533	CcSEcCtD
Polythiazide—Anorexia—Etoposide—sarcoma	0.00532	0.00532	CcSEcCtD
Polythiazide—Diarrhoea—Thiotepa—sarcoma	0.00531	0.00531	CcSEcCtD
Polythiazide—Diarrhoea—Dactinomycin—sarcoma	0.00527	0.00527	CcSEcCtD
Polythiazide—Dizziness—Thiotepa—sarcoma	0.00513	0.00513	CcSEcCtD
Polythiazide—Hypersensitivity—Vincristine—sarcoma	0.00507	0.00507	CcSEcCtD
Polythiazide—Photosensitivity reaction—Epirubicin—sarcoma	0.00502	0.00502	CcSEcCtD
Polythiazide—Paraesthesia—Etoposide—sarcoma	0.00501	0.00501	CcSEcCtD
Polythiazide—Pancreatitis—Doxorubicin—sarcoma	0.00499	0.00499	CcSEcCtD
Polythiazide—Hyperglycaemia—Epirubicin—sarcoma	0.00496	0.00496	CcSEcCtD
Polythiazide—Hypersensitivity—Mitoxantrone—sarcoma	0.00494	0.00494	CcSEcCtD
Polythiazide—Asthenia—Vincristine—sarcoma	0.00494	0.00494	CcSEcCtD
Polythiazide—Vomiting—Thiotepa—sarcoma	0.00494	0.00494	CcSEcCtD
Polythiazide—Vomiting—Dactinomycin—sarcoma	0.0049	0.0049	CcSEcCtD
Polythiazide—Rash—Thiotepa—sarcoma	0.0049	0.0049	CcSEcCtD
Polythiazide—Dermatitis—Thiotepa—sarcoma	0.00489	0.00489	CcSEcCtD
Polythiazide—Headache—Thiotepa—sarcoma	0.00486	0.00486	CcSEcCtD
Polythiazide—Rash—Dactinomycin—sarcoma	0.00486	0.00486	CcSEcCtD
Polythiazide—Decreased appetite—Etoposide—sarcoma	0.00485	0.00485	CcSEcCtD
Polythiazide—Asthenia—Mitoxantrone—sarcoma	0.00481	0.00481	CcSEcCtD
Polythiazide—Jaundice—Epirubicin—sarcoma	0.00478	0.00478	CcSEcCtD
Polythiazide—Constipation—Etoposide—sarcoma	0.00477	0.00477	CcSEcCtD
Polythiazide—Diarrhoea—Vincristine—sarcoma	0.00471	0.00471	CcSEcCtD
Polythiazide—Photosensitivity reaction—Doxorubicin—sarcoma	0.00464	0.00464	CcSEcCtD
Polythiazide—Nausea—Thiotepa—sarcoma	0.00461	0.00461	CcSEcCtD
Polythiazide—Hyperglycaemia—Doxorubicin—sarcoma	0.00459	0.00459	CcSEcCtD
Polythiazide—Diarrhoea—Mitoxantrone—sarcoma	0.00459	0.00459	CcSEcCtD
Polythiazide—Nausea—Dactinomycin—sarcoma	0.00458	0.00458	CcSEcCtD
Polythiazide—Agranulocytosis—Epirubicin—sarcoma	0.00457	0.00457	CcSEcCtD
Polythiazide—Dizziness—Vincristine—sarcoma	0.00455	0.00455	CcSEcCtD
Polythiazide—Urticaria—Etoposide—sarcoma	0.00443	0.00443	CcSEcCtD
Polythiazide—Jaundice—Doxorubicin—sarcoma	0.00442	0.00442	CcSEcCtD
Polythiazide—Vomiting—Vincristine—sarcoma	0.00438	0.00438	CcSEcCtD
Polythiazide—Rash—Vincristine—sarcoma	0.00434	0.00434	CcSEcCtD
Polythiazide—Dermatitis—Vincristine—sarcoma	0.00434	0.00434	CcSEcCtD
Polythiazide—Headache—Vincristine—sarcoma	0.00431	0.00431	CcSEcCtD
Polythiazide—Vomiting—Mitoxantrone—sarcoma	0.00426	0.00426	CcSEcCtD
Polythiazide—Agranulocytosis—Doxorubicin—sarcoma	0.00423	0.00423	CcSEcCtD
Polythiazide—Rash—Mitoxantrone—sarcoma	0.00423	0.00423	CcSEcCtD
Polythiazide—Dermatitis—Mitoxantrone—sarcoma	0.00422	0.00422	CcSEcCtD
Polythiazide—Headache—Mitoxantrone—sarcoma	0.0042	0.0042	CcSEcCtD
Polythiazide—Hypersensitivity—Etoposide—sarcoma	0.00411	0.00411	CcSEcCtD
Polythiazide—Nausea—Vincristine—sarcoma	0.00409	0.00409	CcSEcCtD
Polythiazide—Asthenia—Etoposide—sarcoma	0.004	0.004	CcSEcCtD
Polythiazide—Nausea—Mitoxantrone—sarcoma	0.00398	0.00398	CcSEcCtD
Polythiazide—Diarrhoea—Etoposide—sarcoma	0.00382	0.00382	CcSEcCtD
Polythiazide—Dizziness—Etoposide—sarcoma	0.00369	0.00369	CcSEcCtD
Polythiazide—Muscle spasms—Epirubicin—sarcoma	0.00368	0.00368	CcSEcCtD
Polythiazide—Vomiting—Etoposide—sarcoma	0.00355	0.00355	CcSEcCtD
Polythiazide—Agitation—Epirubicin—sarcoma	0.00352	0.00352	CcSEcCtD
Polythiazide—Rash—Etoposide—sarcoma	0.00352	0.00352	CcSEcCtD
Polythiazide—Dermatitis—Etoposide—sarcoma	0.00351	0.00351	CcSEcCtD
Polythiazide—Headache—Etoposide—sarcoma	0.00349	0.00349	CcSEcCtD
Polythiazide—Vertigo—Epirubicin—sarcoma	0.00344	0.00344	CcSEcCtD
Polythiazide—Leukopenia—Epirubicin—sarcoma	0.00343	0.00343	CcSEcCtD
Polythiazide—Muscle spasms—Doxorubicin—sarcoma	0.00341	0.00341	CcSEcCtD
Polythiazide—Nausea—Etoposide—sarcoma	0.00331	0.00331	CcSEcCtD
Polythiazide—Agitation—Doxorubicin—sarcoma	0.00326	0.00326	CcSEcCtD
Polythiazide—Vertigo—Doxorubicin—sarcoma	0.00318	0.00318	CcSEcCtD
Polythiazide—Leukopenia—Doxorubicin—sarcoma	0.00317	0.00317	CcSEcCtD
Polythiazide—Thrombocytopenia—Epirubicin—sarcoma	0.00306	0.00306	CcSEcCtD
Polythiazide—Anorexia—Epirubicin—sarcoma	0.00298	0.00298	CcSEcCtD
Polythiazide—Thrombocytopenia—Doxorubicin—sarcoma	0.00283	0.00283	CcSEcCtD
Polythiazide—Paraesthesia—Epirubicin—sarcoma	0.00281	0.00281	CcSEcCtD
Polythiazide—Anorexia—Doxorubicin—sarcoma	0.00276	0.00276	CcSEcCtD
Polythiazide—Decreased appetite—Epirubicin—sarcoma	0.00272	0.00272	CcSEcCtD
Polythiazide—Constipation—Epirubicin—sarcoma	0.00267	0.00267	CcSEcCtD
Polythiazide—Paraesthesia—Doxorubicin—sarcoma	0.0026	0.0026	CcSEcCtD
Polythiazide—Decreased appetite—Doxorubicin—sarcoma	0.00251	0.00251	CcSEcCtD
Polythiazide—Urticaria—Epirubicin—sarcoma	0.00248	0.00248	CcSEcCtD
Polythiazide—Constipation—Doxorubicin—sarcoma	0.00247	0.00247	CcSEcCtD
Polythiazide—Hypersensitivity—Epirubicin—sarcoma	0.0023	0.0023	CcSEcCtD
Polythiazide—Urticaria—Doxorubicin—sarcoma	0.0023	0.0023	CcSEcCtD
Polythiazide—Asthenia—Epirubicin—sarcoma	0.00224	0.00224	CcSEcCtD
Polythiazide—Diarrhoea—Epirubicin—sarcoma	0.00214	0.00214	CcSEcCtD
Polythiazide—Hypersensitivity—Doxorubicin—sarcoma	0.00213	0.00213	CcSEcCtD
Polythiazide—Asthenia—Doxorubicin—sarcoma	0.00208	0.00208	CcSEcCtD
Polythiazide—Dizziness—Epirubicin—sarcoma	0.00207	0.00207	CcSEcCtD
Polythiazide—Vomiting—Epirubicin—sarcoma	0.00199	0.00199	CcSEcCtD
Polythiazide—Diarrhoea—Doxorubicin—sarcoma	0.00198	0.00198	CcSEcCtD
Polythiazide—Rash—Epirubicin—sarcoma	0.00197	0.00197	CcSEcCtD
Polythiazide—Dermatitis—Epirubicin—sarcoma	0.00197	0.00197	CcSEcCtD
Polythiazide—Headache—Epirubicin—sarcoma	0.00196	0.00196	CcSEcCtD
Polythiazide—Dizziness—Doxorubicin—sarcoma	0.00191	0.00191	CcSEcCtD
Polythiazide—Nausea—Epirubicin—sarcoma	0.00186	0.00186	CcSEcCtD
Polythiazide—Vomiting—Doxorubicin—sarcoma	0.00184	0.00184	CcSEcCtD
Polythiazide—Rash—Doxorubicin—sarcoma	0.00182	0.00182	CcSEcCtD
Polythiazide—Dermatitis—Doxorubicin—sarcoma	0.00182	0.00182	CcSEcCtD
Polythiazide—Headache—Doxorubicin—sarcoma	0.00181	0.00181	CcSEcCtD
Polythiazide—Nausea—Doxorubicin—sarcoma	0.00172	0.00172	CcSEcCtD
